Ligand validation:3RVD

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 3RVD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3RVD_NAD_C_401	56%	17%	0.183	0.957	1.67	1.92	8	13	2	0	100%	1
3RVD_NAD_G_401	56%	17%	0.196	0.97	1.66	1.93	8	13	1	0	100%	1
3RVD_NAD_A_401	54%	19%	0.185	0.952	1.52	1.93	10	13	3	0	100%	1
3RVD_NAD_Q_401	54%	18%	0.207	0.973	1.7	1.86	8	12	1	0	100%	1
3RVD_NAD_O_401	54%	20%	0.214	0.98	1.45	1.9	7	13	0	0	100%	1
3RVD_NAD_B_401	52%	17%	0.204	0.965	1.65	1.93	8	13	1	0	100%	1
3RVD_NAD_F_401	47%	16%	0.199	0.94	1.69	1.98	8	13	6	0	100%	1
3RVD_NAD_D_401	32%	18%	0.242	0.915	1.49	2.03	9	13	6	0	100%	1
3RVD_NAD_E_401	31%	18%	0.25	0.918	1.49	1.99	7	13	5	0	100%	1
3RVD_NAD_H_401	22%	18%	0.25	0.868	1.54	1.98	7	13	13	0	100%	1
3QV1_NAD_D_335	92%	24%	0.084	0.975	1.6	1.53	5	6	1	0	100%	1
3K2B_NAD_O_335	68%	21%	0.17	0.984	1.41	1.88	6	14	1	0	100%	1
6KEZ_NAD_C_401	49%	6%	0.207	0.955	2.59	2.57	24	18	6	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.